[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342677-105":59,"doc-detail-342677-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluating-homologous-recombination-activity-in-tissues-to-predict-the-risk-of-hereditary-breast-and-ovarian-cancer-and-olaparib-sensitivity","Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity","","Accurate assessment of homologous recombination (HR) activity supports diagnosis of hereditary breast and ovarian cancer (HBOC) and prediction of response to PARP inhibitors. HR deficiency arises when DNA double-stranded breaks are not properly repaired, often due to germline alterations in HR genes such as BRCA1/BRCA2. Using ASHRA, HR activity was evaluated in lymphoblastoid cells and xenograft tumor tissues that model clinically available samples, enabling detection of BRCA1-linked HR deficiency and quantitative correlation with olaparib effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluating-homologous-recombination-activity-in-tissues-to-predict-the-risk-of-hereditary-breast-and-ovarian-cancer-and-olaparib-sensitivity/342677/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluating-homologous-recombination-activity-in-tissues-to-predict-the-risk-of-hereditary-breast-and-ovarian-cancer-and-olaparib-sensitivity/342677.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the role of homologous recombination (HR) in cancer biology?","Question",{"text":112,"@type":113},"HR repairs DNA damage, including double-stranded breaks and other replication-associated lesions. HR deficiency leads to genomic instability and increases carcinogenesis risk.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is HR activity evaluation important for hereditary breast and ovarian cancer (HBOC)?",{"text":117,"@type":113},"HR deficiency is linked to sensitivity to PARP inhibitors and DNA-damaging agents, so measuring HR activity can help diagnose HBOC and forecast therapeutic effects.",{"name":119,"@type":110,"acceptedAnswer":120},"How does ASHRA support predicting olaparib sensitivity?",{"text":121,"@type":113},"ASHRA quantitatively measures HR activity in clinically relevant samples, including lymphoblastoid cells and xenograft tumor tissues. HR activity levels in these tissues correlated with the observed effects of olaparib.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342677,1790053663,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEvaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity  \nTokiwa Motonari1, Yuki Yoshino2,3*, Moe Haruta 3, Shino Endo 3, Shota Sasaki4, Minoru Miyashita1, Hiroshi Tada1, Gou Watanabe5, Toshiro Kaneko4, Takanori Ishida1 & Natsuko Chiba2,3*  \nHomologous recombination (HR) repairs DNA damage including DNA double-stranded breaks and alterations in HR-related genes results in HR deficiency. Germline alteration of HR-related genes, such as BRCA1 and BRCA2, causes hereditary breast and ovarian cancer (HBOC) . Cancer cells with HR deficiency are sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors and DNA-damaging agents. Thus, accurately evaluating HR activity is useful for diagnosing HBOC and predicting the therapeutic effects of anti-cancer agents. Previously, we developed an assay for site-specific HR activity (ASHRA) that can quantitatively evaluate HR activity and detect moderate HR deficiency. HR activity in cells measured by ASHRA correlates with sensitivity to the PARP inhibitor, olaparib. In this study, we applied ASHRA to lymphoblastoid cells and xenograft tumor tissues, which simulate peripheral blood lymphocytes and tumor tissues, respectively, as clinically available samples. We showed that ASHRA could be used to detect HR deficiency in lymphoblastoid cells derived from a BRCA1 pathogenic variant carrier. Furthermore, ASHRA could quantitatively measure the HR activity in xenograft tumor tissues with HR activity that was gradually suppressed by inducible BRCA1 knockdown. The HR activity of xenograft tumor tissues quantitatively correlated with the effect of olaparib. Our data suggest that ASHRA could be a useful assay for diagnosing HBOC and predicting the efficacy of PARP inhibitors.  \nHomologous recombination (HR) contributes to the repair of DNA damage, including DNA double-stranded breaks (DSBs), inter-strand crosslinks, and stalled replication forks1,2. HR deficiency results in failure to repair DNA damage, which induces genomic instability and carcinogenesis3. Deleterious mutations or insufficient expression of HR-related genes results in HR deficiency. Germline alteration of the HR-related genes BRCA1 and BRCA2 cause hereditary breast and ovarian cancer (HBOC)3. Furthermore, a substantial proportion of spontaneous cancers in various organs contain mutations in HR-related genes4. Cancer cells with HR deficiency show increased sensitivity to cancer therapeutics including poly (ADP-ribose) polymerase (PARP) inhibitors, DNA-damaging agents, such as platinum reagents, and ionizing radiation; these agents create DNA damage that is repaired by HR5,6. Thus, evaluating HR activity is useful for diagnosing HBOC and predicting the effects of cancer therapeutics.  \nTo diagnose HBOC, genetic tests using peripheral blood lymphocytes are performed to detect germline pathogenic variants of BRCA1/2, other HR-related genes, and other hereditary cancer-causing genes using multi-gene  \n1Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-Machi, Aoba-Ku, Sendai, Miyagi 980-8575, Japan. 2Department of Cancer Biology, Institute of Development, Aging and Cancer (IDAC), Tohoku University, 4-1 Seiryomachi Aoba-Ku, Sendai, Miyagi 980-8575, Japan. 3Department of Cancer Biology, Tohoku University Graduate School of Medicine, 4-1 Seiryomachi Aoba-Ku, Sendai, Miyagi 980-8575, Japan. 4Department of Electronic Engineering, Tohoku University, 6-6-05 Aoba Aramaki, Aoba-ku, Sendai 980-8579, Japan. 5Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro,  \nMiyagino-ku, Sendai 983-8512, Japan.*[email: yuki.yoshino.c8@tohoku.ac.jp](email: yuki.yoshino.c8@tohoku.ac.jp); [natsuko.chiba.c7@tohoku.ac.jp](natsuko.chiba.c7@tohoku.ac.jp)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \npanels. Although the use","cbCaib8JAPLPkAJZ","https://ap.wps.com/l/cbCaib8JAPLPkAJZ","pdf",2137679,13,"English","# Background\n## HR deficiency and therapeutic sensitivity\n## Limitations of existing diagnostic approaches\n# Methods and Application\n## Using ASHRA on accessible cell and tissue models\n# Results and Implications\n## Detecting HR deficiency and predicting olaparib response","[{\"question\":\"What is the role of homologous recombination (HR) in cancer biology?\",\"answer\":\"HR repairs DNA damage, including double-stranded breaks and other replication-associated lesions. HR deficiency leads to genomic instability and increases carcinogenesis risk.\"},{\"question\":\"Why is HR activity evaluation important for hereditary breast and ovarian cancer (HBOC)?\",\"answer\":\"HR deficiency is linked to sensitivity to PARP inhibitors and DNA-damaging agents, so measuring HR activity can help diagnose HBOC and forecast therapeutic effects.\"},{\"question\":\"How does ASHRA support predicting olaparib sensitivity?\",\"answer\":\"ASHRA quantitatively measures HR activity in clinically relevant samples, including lymphoblastoid cells and xenograft tumor tissues. HR activity levels in these tissues correlated with the observed effects of olaparib.\"}]","Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity | PDF",1790047686,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03d79d4b033e6b6a3fa60cad34bdb002.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4560dcf9513630db085a9b608dfb9c9c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74651f88bc8b54fe610776953d66fe7e.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca021afd36b3cae09d741002cce856d2.webp",980,1287]